adr_usa_0433|CALT|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0433|CALT|Long Name|Calliditas Therapeutics AB Total Current Assets (Quarterly) (USD)|Calliditas Therapeutics AB Cash and Short Term Investments (Quarterly) (USD)|Calliditas Therapeutics AB Inventories (Quarterly) (USD)|Calliditas Therapeutics AB Net PP&E (Quarterly) (USD)|Calliditas Therapeutics AB Goodwill and Intangibles (Quarterly) (USD)|Calliditas Therapeutics AB Total Liabilities (Quarterly) (USD)|Calliditas Therapeutics AB Total Current Liabilities (Quarterly) (USD)|Calliditas Therapeutics AB Total Long Term Liabilities (Quarterly) (USD)|Calliditas Therapeutics AB Total Deposits (Quarterly) (USD)|Calliditas Therapeutics AB Book Value (Quarterly) (USD)|Calliditas Therapeutics AB Retained Earnings (Quarterly) (USD)|Calliditas Therapeutics AB Treasury Stock (Quarterly) (USD)|Calliditas Therapeutics AB EV to Revenues|Calliditas Therapeutics AB EV to Earnings|Calliditas Therapeutics AB EV to Free Cash Flow|Calliditas Therapeutics AB EV to Assets (Quarterly)|Calliditas Therapeutics AB PS Ratio|Calliditas Therapeutics AB PE Ratio|Calliditas Therapeutics AB Price to Book Value|Calliditas Therapeutics AB PEG Ratio|Calliditas Therapeutics AB Debt to Equity Ratio|Calliditas Therapeutics AB Dividend Yield|Calliditas Therapeutics AB Shareholder Yield (TTM)|Calliditas Therapeutics AB Percent of Shares Outstanding Short|Calliditas Therapeutics AB Total Receivables (Quarterly) (USD)|Calliditas Therapeutics AB Total Payables (Quarterly) (USD)|Calliditas Therapeutics AB Total Capital Stock (Quarterly) (USD)|Calliditas Therapeutics AB Return on Invested Capital|Calliditas Therapeutics AB Quality Ratio Score|Calliditas Therapeutics AB Momentum Score|Calliditas Therapeutics AB Beta (1Y)|Calliditas Therapeutics AB Sustainable Growth Rate (TTM)|Calliditas Therapeutics AB Institutional Investor Ownership Percentage|Calliditas Therapeutics AB Average Diluted Shares Outstanding (Quarterly)|Calliditas Therapeutics AB Total Employees (Annual)|Calliditas Therapeutics AB EPS Diluted (Quarterly) (USD)|Calliditas Therapeutics AB Dividend Per Share (Quarterly) (USD)|Calliditas Therapeutics AB Revenue (Quarterly) (USD)|Calliditas Therapeutics AB Gross Profit (Quarterly) (USD)|Calliditas Therapeutics AB SG&A Expense (Quarterly) (USD)|Calliditas Therapeutics AB Pre-Tax Income (Quarterly) (USD)|Calliditas Therapeutics AB Net Income (Quarterly) (USD)|Calliditas Therapeutics AB Net Interest Income (Quarterly) (USD)|Calliditas Therapeutics AB Price (USD)|Calliditas Therapeutics AB Total Return Price (USD)|Calliditas Therapeutics AB Enterprise Value (USD)|Calliditas Therapeutics AB 30-Day Average Daily Volume|Calliditas Therapeutics AB 1 Year Price Returns (Daily)||
adr_usa_0433|CALT|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0433|CALT|201703||||||||||||||||||||||||||||||||||33.2323||-0.0397||||0.7535|-1.3177|-1.3177|-0.0842|||||||
adr_usa_0433|CALT|201706||||||||||||||||||||||||||||||||||14.6919||-0.1249||||1.2119|-1.8298|-1.8298|-0.0709|||||||
adr_usa_0433|CALT|201709||||||||||||||||||||||||||||||||||15.2027||-0.1489||||1.5407|-2.2615|-2.2615|-0.1114|||||||
adr_usa_0433|CALT|201712|7.5558|7.0132||0.0193||3.5599|3.5599|0||4.0569|-39.181|||||||||||||||1.6733|0.0816|||||||16.5491||-0.3125||||4.102|-4.8724|-4.8724|0.0043|||||||
adr_usa_0433|CALT|201803|6.7806|6.3645||0.0174||3.848|3.848|0||2.9909|-43.1644|||||||||||||||1.0309|0.08|||||||16.673||-0.2826||||0.9217|-4.7186|-4.7186|0.0025|||||||
adr_usa_0433|CALT|201806|7.3292|1.8849||0.0146||6.5697|6.5697|0||0.8118|-42.069|||||||||||||||0.6578|0.1472|||||||16.855|10|-0.1248||||0.9887|-2.1008|-2.1008|0.0025|||||||
adr_usa_0433|CALT|201809|77.3556|77.1866||0.0134||3.1809|3.1809|0||74.2265|-46.2915|||||||||||||||2.171|0.1585|||||||37.157|10|-0.1017||||0.8159|-3.511|-3.511|-0.0145|||||||
adr_usa_0433|CALT|201812|72.1559|71.9561||0.0119|0|3.3677|3.3677|0||68.8381|-50.7251||||||||||||||0|2.5215|0.1568|||||||35.85|10|-0.1337||||0.8629|-4.8881|-4.8881|0.0095|||||||
adr_usa_0433|CALT|201903|65.0398|64.2205||0.0421||3.1837|3.1837|0||61.9348|-53.5971|||||||||||||||2.2384|0.1515|||||||35.2023|13|-0.1321||||1.0698|-4.6449|-4.6449|0.0183|||||||
adr_usa_0433|CALT|201906|75.1394|57.7106||0.7998||5.1201|4.594|0.5261||71.1073|-44.7729||||||||||0|||||3.5046|0.1519|||||||17.7185|14|0.4976||14.6369||2.0113|8.8056|8.8056|-0.2349|||||||
adr_usa_0433|CALT|201909|83.4576|82.2964||0.6846|1.6126|3.1565|2.7216|0.435||82.7964|-47.5388||||||||||0|||||1.5273|0.1582|||||||41.1689|14|-0.1356||||1.0741|-5.231|-5.231|0.2607|||||||
adr_usa_0433|CALT|201912|87.8718|80.6386||0.6488|1.7193|6.1135|5.7113|0.4023||84.3338|-52.2326||||||||||0||||4.9853|2.6176|0.1657|||||||38.7271|14|-0.0646||4.8523||2.4779|-2.3928|-2.4008|0.0159|||||||
adr_usa_0433|CALT|202003|75.8693|72.6629||0.5502|1.6023|5.9573|5.6991|0.2581||72.258|-55.0332||||||||||0||||0|2.8287|0.1544|-7.0234||||-7.3193||38.7076|17|-0.1716||0.0493||1.8727|-6.6217|-6.6256|0.8994|||||||
adr_usa_0433|CALT|202006|157.011|156.5534||0.5229|1.7232|6.6282|6.3843|0.2439||152.8579|-65.7697|||-73.2836|-81.7896|5.1081||158.5346|3.6379|||0||0.0158|0|3.1663|0.2057||||||22.1716|20.4578|30|-0.3103||||1.9444|-6.3369|-6.3438|0.5486|23.2|23.2|399.5321|||23.605|23.605
adr_usa_0433|CALT|202009|||||||||||||||-90.6361||||3.9206|||0||0.1636|||||||||21.2849|||||||||||24|24|442.7458|52531.4333||24.08|24.08